Johnson & Johnson 's revenues have generally been increasing over the last several years . As of 2019 , Johnson & Johnson 's total net income was estimated to be about 15.12 billion U.S. dollars . This is a slight decrease from the previous year when net income was at about 15.3 billion U.S. dollars . Johnson & Johnson has been majorly impacted by tax laws that cost the company about 13.6 billion dollars in 2018 . Johnson & Johnson 's revenue overview Johnson & Johnson is a multinational company that is headquartered in New Brunswick , New Jersey , in the United States . The company 's largest business segment is their pharmaceutical segment , but the company also operates in medical devices , diagnostics , and consumer products . Regionally the United States makes up the largest proportion of Johnson & Johnson 's sales , followed by Europe . Johnson & Johnson 's global R & D positioning Johnson & Johnson has been ranked second among global pharmaceutical companies based on their research and development spending in 2018 . Johnson & Johns is also ranked among the top three pharmaceutical companies based on the number of drugs developed in-house . Similarly , Johnson & Johnson is ranked among the top three pharmaceutical companies based on the number of drugs in development in 2019 .
